To investigate the effects of dasatinib and Eto on breast cancer stem cells, the proportion of ALDH1-positive cells was examined before and after the treatments with these agents using immunocytochemistry and Aldefluor assay. The gene discussed is ALDH1A1; the disease is breast carcinoma.